Unknown

Dataset Information

0

Bone marrow-induced Mef2c deficiency delays B-cell development and alters the expression of key B-cell regulatory proteins.


ABSTRACT: The Mef2 family transcriptional regulator Mef2c (myocyte enhancer factor 2c) is highly expressed in maturing bone marrow and peripheral mature B-cells. To evaluate the role of this transcription factor in B-cell development, we generated a B-cell-specific conditional deletion of Mef2c using the Mb-1-Cre transgene that is expressed during the early stages of immunoglobulin rearrangement. Young mice possessing this defect demonstrated a significant impairment in B-cell numbers in bone marrow and spleen. This phenotype was evident in all B-cell subsets; however, as the animals mature, the deficit in the peripheral mature B-cell compartments was overcome. The absence of Mef2c in mature B-cells led to unique CD23+ and CD23- subsets that were evident in Mef2c knockout primary samples as well as Mef2c-deficient cultured, differentiated B-cells. Genome-wide expression analysis of immature and mature B-cells lacking Mef2c indicated altered expression for a number of key regulatory proteins for B-cell function including Ciita, CD23, Cr1/Cr2 and Tnfsf4. Chromatin immunoprecipitation analysis confirmed Mef2c binding to the promoters of these genes indicating a direct link between the presence (or absence) of Mef2c and altered transcriptional control in mature B-cells.

SUBMITTER: Debnath I 

PROVIDER: S-EPMC3555695 | biostudies-literature | 2013 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bone marrow-induced Mef2c deficiency delays B-cell development and alters the expression of key B-cell regulatory proteins.

Debnath Irina I   Roundy Kirstin M KM   Pioli Peter D PD   Weis Janis J JJ   Weis John H JH  

International immunology 20121019 2


The Mef2 family transcriptional regulator Mef2c (myocyte enhancer factor 2c) is highly expressed in maturing bone marrow and peripheral mature B-cells. To evaluate the role of this transcription factor in B-cell development, we generated a B-cell-specific conditional deletion of Mef2c using the Mb-1-Cre transgene that is expressed during the early stages of immunoglobulin rearrangement. Young mice possessing this defect demonstrated a significant impairment in B-cell numbers in bone marrow and s  ...[more]

Similar Datasets

2012-05-31 | E-GEOD-34210 | biostudies-arrayexpress
2012-06-01 | GSE34210 | GEO
| S-EPMC4987520 | biostudies-literature
| S-EPMC10725948 | biostudies-literature
| S-EPMC9877140 | biostudies-literature
| S-EPMC7073037 | biostudies-literature
| S-EPMC4351456 | biostudies-literature
| S-EPMC5361408 | biostudies-literature
| S-EPMC3254014 | biostudies-other
| S-EPMC6075590 | biostudies-literature